FYZANT Trademark

Trademark Overview

On Friday, August 28, 2020, a trademark application was filed for FYZANT with the United States Patent and Trademark Office. The USPTO has given the FYZANT trademark a serial number of 90145023. The federal status of this trademark filing is REGISTERED as of Tuesday, March 21, 2023. This trademark is owned by Fyzant Pharma Pte. Ltd.. The FYZANT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biomedical research services; research and development in the field of biotechnology; Scientific and technological services, namely, analysis in the field of molecular biology; pharmaceutical research and development services; research relating to molecular sciences; research relating to medicine; medical research
fyzant

General Information

Serial Number90145023
Word MarkFYZANT
Filing DateFriday, August 28, 2020
Status700 - REGISTERED
Status DateTuesday, March 21, 2023
Registration Number7002902
Registration DateTuesday, March 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Goods and ServicesBiomedical research services; research and development in the field of biotechnology; Scientific and technological services, namely, analysis in the field of molecular biology; pharmaceutical research and development services; research relating to molecular sciences; research relating to medicine; medical research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 2, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFyzant Pharma Pte. Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSingapore 118261
SG
Party NameFyzant Pharma Pte. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSingapore 118261
SG
Party NameFyzant Pharma Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSingapore 118261
SG

Trademark Events

Event DateEvent Description
Tuesday, March 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 23, 2022CASE RETURNED TO EXAMINATION
Wednesday, November 23, 2022NOTICE OF ALLOWANCE CANCELLED
Tuesday, November 22, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, November 22, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, November 21, 2022ASSIGNED TO PETITION STAFF
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 3, 2022SOU EXTENSION 3 GRANTED
Thursday, November 3, 2022SOU EXTENSION 3 FILED
Thursday, November 3, 2022TEAS EXTENSION RECEIVED
Thursday, November 3, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, April 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 12, 2022SOU EXTENSION 2 GRANTED
Tuesday, April 12, 2022SOU EXTENSION 2 FILED
Tuesday, April 12, 2022TEAS EXTENSION RECEIVED
Tuesday, November 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 29, 2021SOU EXTENSION 1 GRANTED
Friday, October 29, 2021SOU EXTENSION 1 FILED
Friday, October 29, 2021TEAS EXTENSION RECEIVED
Tuesday, May 4, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 30, 2020NON-FINAL ACTION E-MAILED
Wednesday, December 30, 2020NON-FINAL ACTION WRITTEN
Wednesday, December 30, 2020ASSIGNED TO EXAMINER
Friday, October 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 1, 2020NEW APPLICATION ENTERED

Related Keywords

fyzant research services molecular field development relating pharmaceutical medical biology medicine